Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Fatal vancomycin- and linezolid-resistant Enterococcus faecium sepsis in a child undergoing allogeneic haematopoietic stem cell transplantation for beta-thalassaemia major
Fatal vancomycin- and linezolid-resistant Enterococcus faecium sepsis in a child undergoing allogeneic haematopoietic stem cell transplantation for beta-thalassaemia major JOURNAL OF MEDICAL MICROBIOLOGY Fossati, M., Cappelli, B., Biral, E., Chiesa, R., Biffi, A., Ossi, C., Moro, M., Cirillo, D. M., Clementi, M., Soliman, C., Ciceri, F., Roncarolo, M. G., Fumagalli, L., Marktel, S. 2010; 59 (7): 839-842Abstract
Recently vancomycin-resistant and sporadically linezolid-resistant Enterococcus species have been described in adults. We report what we believe to be the first case of a child with prolonged bone marrow aplasia following haematopoietic stem cell transplantation developing a fatal sepsis caused by Enterococcus faecium resistant to glycopeptides and linezolid.
View details for DOI 10.1099/jmm.0.018598-0
View details for Web of Science ID 000279838400015
View details for PubMedID 20299507